Editorial: Advancing the Frontiers of Non-Invasive Neuromodulation in Research and Clinical Practice
First-pass extracted concept
non-invasive neuromodulation
Candidate: concept label3 source documents7 linked claims
Live refresh every 5sNext refresh in 5s
Evidence Snippets
Non-invasive neuromodulation presents as an exciting potential adjunctive therapy for people with drug-resistant epilepsy (DRE).
Non-invasive neuromodulation has also shown some promise in modulating the visual cortex
Supporting Sources
Source 1primary paper2026PMC
Linked Claims
The paper is an editorial focused on advancing non-invasive neuromodulation in research and clinical practice.
Although current visual neurorestoration methods have shown promise individually, improvements in vision have been modest at best.
Non-invasive neuromodulation has shown some promise in modulating the visual cortex.
Achieving functional vision restoration will require further development of cellular therapies, genetic engineering, transplantation, and neuromodulation in a multidisciplinary effort.
The planned systematic review and meta-analysis will evaluate efficacy and safety of multiple non-invasive brain and nerve stimulation modalities for drug-resistant epilepsy and compare intervention types where applicable.
Quoted textsource-backed
The proposed systematic review and meta-analysis will investigate the efficacy of repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), low-intensity focused ultrasound (LI-FUS), transcutaneous vagus nerve stimulation (tVNS), and trigeminal nerve stimulation (TNS) for seizure reduction amongst patients diagnosed with DRE, with comparisons also being made between intervention types where applicable.
The review frames non-invasive neuromodulation as having the advantage of avoiding neurocognitive and systemic adverse events associated with anti-seizure medications and avoiding significant risks associated with resective surgery and invasive neuromodulation techniques.
Quoted textsource-backed
A major advantage of this approach is the absence of the neurocognitive and systemic adverse events commonly associated with anti-seizure medications (ASM), and the significant risks that accompany both resective epilepsy surgery and invasive neuromodulation techniques.
Current visual neurorestoration efforts target multiple points along the visual pathway from retina to diencephalon to cortex.